Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.47 |
| ▸ | NQO2 | P16083 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11052717 | 0.91 | CYP1A2 (0.46) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL4521520 | 0.91 | MTNR1A (0.45) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL3113301 | 0.91 | CYP1A2 (0.44) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL11051055 | 0.88 | CYP1A2 (0.47) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL14814398 | 0.88 | CNR1 (0.43) | CYP1A2CYP2C19CYP2C9MTNR1ATDP1 | |
| SCHEMBL4526077 | 0.86 | CNR1 (0.43) | CYP1A2CYP2C19CYP2C9MTNR1ATDP1 | |
| SCHEMBL3807751 | 0.86 | HTR1B (0.55) | CYP1A2CYP2C19CYP2D6NQO2CDYL | |
| SCHEMBL6711225 | 0.86 | MTNR1A (0.43) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL1180264 | 0.85 | TDP1 (0.56) | CYP1A2MTNR1ATDP1CDYLAKR1B1 | |
| SCHEMBL4511132 | 0.85 | CYP1A2 (0.40) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 515 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117897055-A | Method for reducing abnormal odor | 奇华顿股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-7772009-B2 | Room temperature phosphorescence apparatus and methods | SCR Research, LLC (US) | 2010-08-10 | — | — | US | claimed |
| WO-2007061574-A2 | ROOM TEMPERATURE PHOSPHORESCENCE APPARATUS AND METHODS | SCA RESEARCH, LLC (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070117215-A1 | Room temperature phosphorescence apparatus and methods | POLYMER CONCEPTS TECHNOLOGIES PBY, INC. | 2007-05-24 | — | — | US | claimed |
| EP-0142886-B1 | COMPOSITIONS CONTAINING ODOR PURIFIED PROTEOLYTIC ENZYMES AND PERFUMES | THE PROCTER & GAMBLE COMPANY (US) | 1988-03-16 | — | — | EP | claimed |
| CN-117980454-B | Aldehyde composition | 三菱瓦斯化学株式会社 | 2026-05-19 | — | — | CN | disclosed |
| US-12630783-B2 | Muguet type fragrance compounds | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | SYMRISE AG (DE) | 2026-03-17 | — | — | US | disclosed |
| US-12545851-B2 | Fragrances with note of lily of the valley | SYMRISE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-4045490-B1 | NEW AROMATIC MONOTHIOKETALS AS FRAGRANCES | SYMRISE AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-4624559-A2 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | Symrise AG (DE) | 2025-10-01 | — | — | EP | disclosed |
| CN-120202281-A | Substituted 1, 3-dioxolan-4-ones and 1, 3-dioxane-4-ones as perfume ingredients | 巴斯夫欧洲公司 | 2025-06-24 | — | — | CN | disclosed |
| EP-1215189-A1 | Process for the preparation of isolongifolanol | HAARMANN & REIMER GMBH (DE) | 2002-06-19 | — | — | EP | disclosed |
| WO-2002024857-A1 | MULTI-PHASE SOAP | HAARMANN & REIMER GMBH (DE) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002019983-A2 | CLEANSING/CONDITIONING AGENTS CONTAINING MATRIX PARTICLES WITH A PERFUME COMPONENT AND A WASHING-ACTIVE COMPONENT | HAARMANN & REIMER GMBH (DE) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002012157-A1 | NOVEL MACROCYCLIC KETONES | HAARMANN & REIMER GMBH (DE) | 2002-02-14 | — | — | WO | disclosed |
| EP-1111029-A2 | Perfume compositions containing 4,8-dimethyl-3,7-nonadien-2-one | HAARMANN & REIMER GMBH (DE) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001038440-A1 | WAX FORMULATIONS CONTAINING ODORIFEROUS SUBSTANCES | HAARMANN & REIMER GMBH (DE) | 2001-05-31 | — | — | WO | disclosed |
| WO-2001023373-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2001-04-05 | — | — | WO | disclosed |
| EP-1067126-A2 | Tetracyclic acetals | HAARMANN & REIMER GMBH (DE) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | ALG3, FAAH, FAAH2 | CYP1A2 391/4885CYP2C19 1379/4885CYP2C9 1510/4885 |
| US-12630783-B2 | Muguet type fragrance compounds | MGAT1, RFT1, CPT1A | CYP1A2 139/4885CYP2C19 2339/4885CYP2C9 1433/4885 |
| US-12545851-B2 | Fragrances with note of lily of the valley | TRPA1, CDY1; CDY1B, TMEM109 | CYP1A2 1196/4885CYP2C19 2753/4885CYP2C9 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.